Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1™ Implant System

BREA, Calif.: BREA, Calif., Dec. 27, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically driven design of components and forward-thinking treatment protocols, the N1™ implant system represents a...

Click to view original post